582 Results (Page 22 of 24)
US Markets Research Reports
US Neurology Devices Market Analysis
The US Neurology Device Market size is at around $5.31 Bn in 2022 and is projected to reach $8.32 Bn in 2030, exhibiting a CAGR of 5.8% during the forecast period. With increasing emphasis on minimally invasive procedures and revolutionary research being focussed on Neurology diseases like ALS, Alzheimer’s disease, and traumatic Neurology impairment. Major players like Medtronic, GE Healthcare, and Siemens Healthineers are capturing a wider network of stakeholders. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
US Acne Therapeutics Market Analysis
The US acne therapeutics market is expected to witness growth from $4.21 Bn in 2022 to $6.08 Bn in 2030 with a CAGR of 4.7% for the forecasted period 2022-2030 mainly due to increased incidence of acne and demand for cosmeceuticals in the US. The market is segmented by treatment, route of administration, age group, and by distribution channel. Pfizer, Johnson & Johnson, and Padagis are some of the key market players in the US acne therapeutics market.
US Dialysis Market Analysis
The US Dialysis Market is projected to grow from $48.808 Bn in 2022 to $69.410 Bn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market for dialysis services in the US is anticipated to be driven by rising rates of high blood pressure and diabetes. Fresenius Medical Care company is the largest provider of dialysis services and products in the world and is the leader in the US market, with a significant market share.
US Dermatology Drugs Market Analysis
By 2030, it is anticipated that the US Dermatology drugs market will reach a value of $14 Bn from $7.14 Bn in 2022, growing at a CAGR of 8.8% during 2022-2030. The dermatology drug market in the US is dominated by a few large pharmaceutical companies such as Amgen Inc., Eli Lilly, and AbbVie. The dermatology drug market in the US is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel. The major factors affecting the US dermatology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of the US.
US Home Healthcare Market Analysis
The US home healthcare market was valued at $152.31 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.93% from 2022 to 2030 and will reach $241.48 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the cost-effectivity of home healthcare services. The market is segmented by equipment outlook and by services. Some key players in this market are McKesson Medical-Surgical, NxStage Medical (Fresenius Medical Care), Medline Industries Inc., Kindred Healthcare, Brookdale Senior Living, and Sunrise Senior Living.
US Women's Health Market Analysis
The US Women’s Health Market is projected to grow from $16.775 Bn in 2022 to $20.922 Bn by 2030, registering a CAGR of 2.80% during the forecast period of 2022 - 2030. As more women become aware of the importance of taking care of their health and the availability of new and innovative products and technologies, the demand for women's health products and services is increasing. Some key players in the US Women's Health market include Pfizer, Merck, AbbVie, Allergan, GlaxoSmithKline, Lilly, Novo Nordisk, Roche, Sanofi, Teva, Mylan, and Actavis.
US Bioinformatics Market Analysis
The US Bioinformatics market is projected to grow from $6.447 Bn in 2022 to $18.781 Bn by 2030, registering a CAGR of 14.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increased adoption of precision medicine, the growing use of genomics in drug discovery, technological advancements, and the rising volume of biological data created. The market is segmented by technology and by application. Some of the major players include Biovia (USA), IBM Life Sciences (USA), 3rd Millennium Inc (USA), Celera Corporation (USA), Illumina Inc. (USA), Agilent Technologies (USA), Affymetrix (USA), BioWisdom Ltd.
US Breast Cancer Therapeutics Market Analysis
The US breast cancer therapeutics market size is projected to grow to $ 17.48 Bn by 2030 from $7.64 Bn in 2022, exhibiting a CAGR of 10.9% during the forecast period (2022-2030), according to the study conducted by Insights10. A lifetime diagnosis of invasive breast cancer is estimated to occur in 13% of women (1 in 8), and 3% (1 in 39) are prone to mortality, according to the American Cancer Society (US) Statistics 2020. Newer interventions in the competitive landscape are estimated to reach $4.6 Bn in revenues from major players like AstraZeneca, and Daiichii Sankyo thanks to the sizeable market demands.
US Physiotherapy Market Analysis
The US physiotherapy market size was valued at $22.34Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.85% from 2022 to 2030 and will reach $30.22Bn in 2030. The physiotherapy market in US is expected to see steady growth in the coming years, as an aging population, an increase in chronic diseases, greater focus on preventative care and rehabilitation after surgeries. The market is segmented by Product Type, Application Type, and End User. The major players in the US physiotherapy market are BTL Industries, EMS Physio Ltd., DJO Global, Inc., Dynatronics Corporation, Inc., Performance Health, and others.
US Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the US Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Patient Support Programs (PSP) Market, offering unmatched value, accuracy and expert insights.
US Women Health Diagnostic Market Analysis
This report presents a strategic analysis of the US Women Health Diagnostic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Women Health Diagnostic Market, offering unmatched value, accuracy and expert insights.
US Acne Drugs Market Analysis
This report presents a strategic analysis of the US Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Acne Drugs Market, offering unmatched value, accuracy and expert insights.
US Insulin Market Analysis
This report presents a strategic analysis of the US Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Insulin Market, offering unmatched value, accuracy and expert insights.
US Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the US Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
US Oncology Drugs Market Analysis
This report presents a strategic analysis of the US Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
US Skin Antiseptic Products Market Analysis
This report presents a strategic analysis of the US Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.
US Sleep Disorders Market Analysis
This report presents a strategic analysis of the US Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
US Vaccines Market Analysis
This report presents a strategic analysis of the US Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the US Vaccines Market, offering unmatched value, accuracy and expert insights.
US Graft-versus-Host Disease (GvHD) Therapeutics Market Analysis
The US GvHD Therapeutics Market was valued at $1050 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $1589.27 Mn by 2030. The drivers responsible for the growth of this market are the rising incidence of GvHD, advanced treatments, patient-centric treatments, and growing awareness. The competition in the market prevails among players like GSK, Abbott, Takeda, Genzyme, Sanofi, Eli Lily, Mallinckrodt and others.
US Central Nervous System (CNS) Therapeutics Market Analysis
The US Central Nervous System (CNS)Therapeutics Market was valued at $88.2 Bn in 2022 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $124.472 Bn by 2030. The key drivers of this industry include the rising prevalence of CNS diseases, untapped market potential, and technological advancements in the industry. The industry is primarily dominated by players such as Pfizer, Novartis, Teva Pharmaceutical, Otsuka, AbbVie, Merck, and Eli Lilly among others.
US Dental Fluoride Treatment Market Analysis
The US Dental Fluoride Treatment Market was valued at $6,370.2 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $7,267.3 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Procter & Gamble, Colgate Palmolive, Unilever, 3M and Ultradent Products among others.
US Financial Assistance Programs Market Analysis
The US Financial Assistance Programs Market was valued at $11,902.5 Mn in 2023 and is projected to grow at a CAGR of 12.6% from 2023 to 2023, to $27,315.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
US Chronic Pain Therapeutics Market Analysis
The US Chronic Pain Therapeutics Market is anticipated to experience a growth from $31.206 Bn in 2022 to $42.380 Bn by 2030, with a CAGR of 3.9% during the forecast period of 2022-2030. The combination of an aging population, high unmet needs, and the shift towards non-opioid options is reshaping the landscape of chronic pain therapeutics in the US. The US Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Merck, Pfizer, Sanofi, Amgen, Biogen, Teva Pharmaceuticals, etc., among various others.
US Periodontal Therapeutics Market Analysis
The US Periodontal Therapeutics Market was valued at $366.6 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $522.7 Mn by 2030. The US Periodontal Therapeutics Market is growing due to Rise in prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
US Radiology Service Market Analysis
The US Radiology Service Market was valued at $1,680 Mn in 2023 and is predicted to grow at a CAGR of 12.7% from 2023 to 2030, to $3,879.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, geriatric population, and technological advancements. The prominent players of the US Radiology Service Market are Massachusetts General Hospital, Brigham and Women’s Hospital, University of Pittsburgh Medical Centre, John Hopkins Hospital, UCLA-Health Ronald Reagan Medical Centre, and Stanford Healthcare, among others.
